You searched for: kanċerużi (Maltesiska - Engelska)

it-tumuri tal-mast cell huma proliferazzjonijiet kanċerużi tal-mast cells.
mast cell tumours are cancerous proliferations of mast cells.

dawn jaħdmu flimkien billi joqtlu ċ-ċelloli bojod tad-demm kanċerużi.
they act together by killing cancerous white blood cells.

filwaqt li aħna kollha nġorru ċelloli diffettużi, jew kanċerużi, ġeneralment issistema ta’immunità tagħna żżommhom taħt kontroll.
while we all carry defective, or cancerous cells, our immune system usually keeps them under control.

kważi l-pazjenti kollha (38 minn 39) b’nodi limfatiċi kanċerużi ġew individwati b’lymphoseek.
almost all the patients (38 out of 39) with cancerous lymph nodes were identified by lymphoseek.

it- tipi hpv 16 u 18 huma responsabbli għal ~70% ta ’ leżjonijiet pre- kanċerużi relatati ma ’ hpv.
hpv types 16 and 18 are responsible for ~70% of cervical cancer cases and 70% of hpv-related pre-cancerous lesions of the vulva and vagina.

id-docetaxel taffetwa wkoll ċelloli mhux kanċerużi bħaċ-ċelloli tad- demm, u dan jista’ jikkawża xi effetti sekondarji.
docetaxel also affects non-cancer cells such as blood cells, which can cause side effects.

cd20 jinsab kemm fuq ċelluli b normali kif ukoll fuq dawk kanċerużi, iżda mhux fuq ċelluli staminali ematopoetiċi, ċelluli pro-b, ċelluli tal-plażma normali jew tessuti normali oħrajn.
cd20 is found on both normal and malignant b cells, but not on haematopoietic stem cells, pro-b cells, normal plasma cells or other normal tissue.

is-ctcl hi kundizzjoni li fiha ċerti ċelluli tas- sistema tal-limfi tal-ġisem imsejħa t-limfoċiti, isiru kanċerużi u jaffettwaw il-ġilda.
ctcl is a condition in which certain cells of the body’s lymph system called t-lymphocytes become cancerous and affect the skin.